The stock of Guardant Health Inc (NASDAQ:GH) last traded at $35.13, down -3.20% from the previous session.
GH stock price is now 19.52% away from the 50-day moving average and 44.73% away from the 200-day moving average. The market capitalization of the company currently stands at $4.30B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target maintained at $36, Guggenheim recently Upgraded its rating from Neutral to Buy for Guardant Health Inc (NASDAQ: GH). , while ‘Craig Hallum’ rates the stock as ‘Buy’
In other news, Joyce Meghan V., Director sold 100 shares of the company’s stock on Jun 04 ’24. The stock was sold for $2,787 at an average price of $27.87. Upon completion of the transaction, the Director now directly owns 4,621 shares in the company, valued at $0.16 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 18 ’24, Chief Information Officer Kalia Kumud bought 2,187 shares of the business’s stock. A total of $38,963 was incurred on buying the stock at an average price of $17.82. This leaves the insider owning 12,722 shares of the company worth $0.45 million. A total of 5.23% of the company’s stock is owned by insiders.
During the past 12 months, Guardant Health Inc has had a low of $15.81 and a high of $41.06. As of last week, the company has a debt-to-equity ratio of 19.73, a current ratio of 5.95, and a quick ratio of 5.66. The fifty day moving average price for GH is $29.5124 and a two-hundred day moving average price translates $24.28675 for the stock.
The latest earnings results from Guardant Health Inc (NASDAQ: GH) was released for 2024-03-31. The net profit margin was -76.34% and return on equity was -3883.89% for GH. The company reported revenue of $168.49 million for the quarter, compared to $128.71 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 30.9 percent.
